XML 49 R36.htm IDEA: XBRL DOCUMENT v3.24.4

Common Stock, Stock Options and Warrants (Details) - Schedule of Determining the fair Value of Stock Option Grants	Sep. 30, 2024	Sep. 30, 2023
Risk-free interest rate [Member] | Minimum [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	4.62	1.05
Risk-free interest rate [Member] | Minimum [Member] | Citius Oncology [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	4.66	4.11
Risk-free interest rate [Member] | Maximum [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	4.66	2.94
Risk-free interest rate [Member] | Maximum [Member] | Citius Oncology [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	4.66	4.11
Expected dividend yield [Member] | Minimum [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	0	0
Expected dividend yield [Member] | Minimum [Member] | Citius Oncology [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	0	0
Expected dividend yield [Member] | Maximum [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	0	0
Expected dividend yield [Member] | Maximum [Member] | Citius Oncology [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	0	0
Expected term [Member] | Minimum [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	5.5	6.5
Expected term [Member] | Minimum [Member] | Citius Oncology [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	6.5	5.96
Expected term [Member] | Maximum [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	10	10
Expected term [Member] | Maximum [Member] | Citius Oncology [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	6.5	5.96
Expected volatility [Member] | Minimum [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	85	94
Expected volatility [Member] | Minimum [Member] | Citius Oncology [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	87	91
Expected volatility [Member] | Maximum [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	86	110
Expected volatility [Member] | Maximum [Member] | Citius Oncology [Member]
Schedule of Determining the fair Value of Stock Option Grants [Line Items]
fair value of stock option grants	87	91

X

- Definition

Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_EquitySecuritiesFvNiMeasurementInput
Namespace Prefix:	us-gaap_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ValuationAllowanceLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ctxr_CitiusOncologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendPaymentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: